Obesity Epidemic Fuels Push for GLP-1 Coverage Expansion by Biden Administration

 

Krissy Vann | Host, All Things Fitness and Wellness

With 42% of Americans classified as obese, the U.S. faces a growing public health crisis tied to chronic diseases such as diabetes, heart disease, and cancer. The Biden-Harris Administration is addressing this challenge with a proposal to expand Medicare and Medicaid coverage for GLP-1 medications. If approved, this move could provide affordable access to these medications for millions of Americans while creating ripple effects across multiple industries, including fitness.

GLP-1 drugs, originally developed for Type 2 diabetes, have demonstrated significant benefits in weight management and reducing cardiovascular risks by up to 20%. However, the high cost—exceeding $1,000 per month for uninsured individuals—has placed these treatments out of reach for many. The new rule aims to cut out-of-pocket expenses by as much as 95% for some Medicare enrollees and extend Medicaid coverage to approximately four million adults, potentially reshaping access to obesity care. The proposal builds on existing policies, such as the Inflation Reduction Act, which allows Medicare to negotiate drug prices and reduce costs for some of the most expensive medications.

The fitness industry is closely monitoring this shift. Analysts argue that as individuals on GLP-1 medications achieve weight loss, they are more likely to engage with fitness programs to maintain their progress. High-end brands like MIORA by Life Time have launched programs integrating fitness, nutrition, and medical guidance specifically for GLP-1 users, while Equinox has developed personal training plans to support members in forming sustainable health habits alongside their medication use. These initiatives reflect an emerging trend where gyms aim to bridge the gap between medical treatments and lifestyle changes.

For gyms operating on lower budgets, opportunities lie in collaboration with local healthcare providers prescribing GLP-1 medications. By creating accessible fitness programs and educational resources tailored to new users, operators can ease the transition into fitness for those previously hesitant to join a gym. Additionally, the development of app-based or digital solutions could help overcome barriers to entry for individuals unfamiliar with gym culture, offering them a low-pressure introduction to exercise routines.

If implemented, this proposal could mark a significant step in addressing obesity as a multifaceted issue requiring both medical and lifestyle solutions. Expanded coverage for GLP-1 medications has the potential to make these treatments more accessible, opening the door for the fitness industry to engage a broader audience and support Americans in pursuing long-term health improvements. By preparing to meet the needs of GLP-1 users, fitness operators would be well-positioned to play a critical role in fostering healthier lives and tackling one of the nation’s most pressing health challenges.

Elevate Your Expertise: Tune in to Our YouTube Channel for Exclusive Podcasts with fitness and wellness Industry Titans and Game-Changers


 

Check This Out:

 
Previous
Previous

Inactive Nation: Canada Urged to Address $3.9 Billion Physical Inactivity Problem

Next
Next

Purpose Brands Names Tom Leverton as CEO Following Merger of Self Esteem Brands and Orangetheory Fitness